Bunevicius et al. reported that an elevated IL-6 concentration, with a cutoff of 2.0 pg/mL, was significantly associated with shorter survival times in patients with high-grade glioma, with a HR of 4.068 39. The gene discussed is IL6; the disease is central nervous system cancer.